Advances in the study of the role of estrogen and its receptor combined with HPV in cervical cancer microenvironment

doi:10.16352/j.issn.1001-6325.2022.09.1438

Abstract

Abstract: Human papillomavirus (HPV) infection is related to cervical cancer. Estrogen and its receptor combined with HPV oncogene can promote the occurrence of cervical cancer. Moreover, high parity and the use of contraceptives incrcasing the risk of cervical cancer support estrogen and HPV infection synergistically promotes cervical cancer. Estrogen can both combine with HPV responsive elements to change viral gene expression accelerating the process of HPV infection, and develop HPV-positive cervical cancer by exerting immunomodulatory function in tumor microenvironment. Estrogen and its receptor play vital roles in cervical cancer and are expected to be a potential therapeutic target for treatment of cervical cancer.

Key words: estrogen, estrogen receptor, uterine cervical neoplasms, therapy, selective estrogen receptor antagonist

CLC Number:

R737

LI He-tong, REN Jing-jing, WANG Wen-hao, HAO Min. Advances in the study of the role of estrogen and its receptor combined with HPV in cervical cancer microenvironment[J]. Basic & Clinical Medicine, 2022, 42(9): 1438-1442.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.09.1438

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I9/1438

References 25

[1]	Okunade KS. Human papillomavirus and cervical cance[J]. J Obstet Gynaecol, 2020, 40: 602-608.
[2]	Wang Z, Yang A, Yang J, et al. Dietary nutrient intake related to higher grade cervical intraepithelial neoplasia risk: a Chinese population-based study[J].Nutr Metab (Lond), 2020, 17: 100-114.
[3]	Johansson ALV, Fredriksson I, Mellemkjaer L, et al. Cancer survival in women diagnosed with pregnancy-associated cancer: an overview using nationwide registry data in Sweden 1970-2018[J]. Eur J Cancer, 2021, 155: 106-115.
[4]	Loopik DL, IntHout J, Melchers WJG, et al. Oral contraceptive and intrauterine device use and the risk of cervical intraepithelial neoplasia grade III or worse: a population-based study[J]. Eur J Cancer, 2020,124: 102-109.
[5]	Wang T, Jin J, Qian C, et al. Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment[J]. Cancer Cell Int, 2021, 21: 295-308.
[6]	Ramachandran B. Functional association of oestrogen receptors with HPV infection in cervical carcinogenesis[J]. Endocr Relat Cancer, 2017, 24: R99-R108.
[7]	Bttinger P, Schreiber K, Hyjek E, et al. Cooperation of genes in HPV16 E6/E7-dependent cervicovaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens[J]. Carcinogenesis, 2020, 41: 1605-1615.
[8]	De Nola R, Menga A, Castegna A, et al. The crowded crosstalk between cancer cells and stromal microenvironment in gynecological malignancies: biological pathways and therapeutic implication[J]. Int J Mol Sci, 2019,20:2401-2430.
[9]	Chen Y, Gu Y, Gu Y, et al. Long noncoding RNA LINC00899/miR-944/ESR1 axis regulates cervical cancer cell proliferation, migration, and invasion[J]. J Interferon Cytokine Res, 2021, 41: 220-233.
[10]	Gomez-Gomez Y, Organista-Nava J, Ocadiz-Delgado R, et al. The expression of miR-21 and miR-143 is deregu-lated by the HPV16 E7 oncoprotein and 17beta-estradiol[J]. Int J Oncol, 2016, 49: 549-558.
[11]	Wang C, Zhang T, Wang K, et al. ER-alpha36 promotes the malignant progression of cervical cancer mediated by estrogen via HMGA2[J]. Frontiers in oncology, 2021,11:712849. doi: 10.3389/fonc.2021.712849.
[12]	Zhang X, Zhang A, Zhang X, et al. ERa-36 instead of ERa mediates the stimulatory effects of estrogen on the expression of viral oncogenes HPV E6/E7 and the malignant phenotypes in cervical cancer cells[J]. Virus research, 2021, 306: 198602. doi: 10.3389/fonc.2021.712849.
[13]	Fan Q, Huang T, Sun X, et al. miR-130a-3p promotes cell proliferation and invasion by targeting estrogen receptor alpha and androgen receptor in cervical cancer[J]. Exp Ther Med, 2021, 21: 414-424.
[14]	Riera Leal A, Ortiz-Lazareno PC, Jave-Suarez LF, et al. 17β-estradiol-induced mitochondrial dysfunction and Warburg effect in cervical cancer cells allow cell survival under metabolic stress[J]. Int J Oncol, 2020, 56: 33-46.
[15]	Bristol ML, James CD, Wang X, et al. Estrogen attenuates the growth of human papillomavirus-positive epithelial cells[J]. mSphere, 2020, 5:e00049-20. doi: 10.1128/mSphere.00049-20.
[16]	Kumagai K, Takanashi M, Ohno SI, et al. WAPL induces cervical intraepithelial neoplasia modulated with estrogen signaling without HPV E6/E7[J]. Oncogene, 2021, 40: 3695-3706.
[17]	Elson DA, Riley RR, Lacey A, et al. Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis[J]. Cancer Res, 2000, 60: 1267-1275.
[18]	Remoue F, Jacobs N, Miot V, et al. High intraepithelial expression of estrogen and progesterone receptors in the transformation zone of the uterine cervix[J]. Am J Obstet Gynecol, 2003,189: 1660-1665.
[19]	Spurgeon ME, Uberoi A, McGregor SM, et al. A novel in vivo infection model to study papillomavirus-mediated disease of the female reproductive tract[J]. mBio, 2019, 10:e00180-19. doi: 10.1128/mBio.00180-19.
[20]	De Nola R, Loizzi V, Cicinelli E, et al. Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications[J]. Crit Rev Oncol Hematol, 2021,162: 103343. doi: 10.1016/j.critrevonc.2021.103343.
[21]	Jayshree RS. The immune microenvironment in human papilloma virus-induced cervical lesions-evidence for estrogen as an immunomodulator[J]. Front Cell Infect Microbiol, 2021, 11: 649815. doi: 10.3389/fcimb.2021.649815.
[22]	Ramachandran B, Murhekar K, Sundersingh S. SERMs suppresses the growth of ERα positive cervical cancer xenografts through predominant inhibition of extra-nuclear ERalpha expression[J]. Am J Cancer Res, 2021, 11: 3335-3353.
[23]	Kim L, Park SA, Park H, et al. Bazedoxifene, a GP130 Inhibitor, modulates EMT signaling and exhibits antitumor effects in HPV-positive cervical cancer[J]. Int J Mol Sci, 2021, 22:8693-8706.
[24]	Chauhan N, Maher DM, Yallapu MM, et al. A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth[J]. Sci Rep, 2019, 9:10917-10929.
[25]	Kwon S, Ahn SH, Jeong WJ, et al. Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma[J]. J Transl Med, 2020,18: 240-252.